Cinnamon for Migraines: Evidence Review

There is insufficient clinical evidence to recommend cinnamon for migraine treatment.

Proposed Mechanisms (Preclinical)

  • Cinnamaldehyde, cinnamic acid: anti-inflammatory (NF-κB inhibition), antioxidant, TRPA1 modulation.
  • May affect CGRP pathway (key migraine mediator) – theoretical.

Human Evidence

  • No randomized controlled trials (RCTs) of cinnamon for migraine prophylaxis or acute treatment.
  • One small open-label study (cinnamon + ginger + feverfew) showed modest reduction in frequency – confounded by polyherbal formulation.
  • Anecdotal reports only.

Safety & Interactions

  • Cassia cinnamon (common) contains coumarin – hepatotoxic at high doses (>0.1 mg/kg/day). Ceylon cinnamon has negligible coumarin.
  • Interactions: anticoagulants (additive effect), diabetes meds (hypoglycemia risk), hepatotoxic drugs.
  • Allergic reactions (contact dermatitis, oral allergy syndrome).

Evidence-Based Migraine Treatments

  • Acute: Triptans, NSAIDs, gepants (ubrogepant, rimegepant), lasmiditan, dihydroergotamine.
  • Preventive: Beta-blockers, topiramate, valproate, CGRP mAbs (erenumab, fremanezumab, galcanezumab, eptinezumab), gepants (atogepant, rimegepant), onabotulinumtoxinA (chronic).
  • Non-pharmacologic: CBT, biofeedback, neuromodulation (Cefaly, gammaCore), trigger management.

Cinnamon may be used as complementary flavoring, but not as a substitute for proven therapy. Discuss supplements with your neurologist.

Migraine - Related Articles